638PTwo Year Survival and Safety Update for Esophageal Squamous Cell Carcinoma Treated With Nivolumab (ATTRACTION-01/ONO-4538-07)

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx369.022